Form 4: W.K. Kellogg Foundation Trust Sells Kellanova Shares Under 10b5-1 Plan

The W.K. Kellogg Foundation Trust reported the sale of 114,583 shares of Kellanova common stock for approximately $9.14 million, executed under a pre-arranged 10b5-1 trading plan.

Summary

• The W.K. Kellogg Foundation Trust and W.K. Kellogg Foundation, identified as a 10% owner and having director relationships with Kellanova (K), reported a transaction.
• On July 28, 2025, the Trust disposed of 114,583 shares of Kellanova common stock.
• The shares were sold at a price of $79.7883 per share, totaling approximately $9,140,000.
• Following this transaction, the W.K. Kellogg Foundation Trust beneficially owns 45,555,786 shares of Kellanova common stock.
• The sale was executed pursuant to trading instructions given by the Trust on May 7, 2024, which are intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled sale by a significant institutional shareholder. While a reduction in stake could be seen as slightly negative, the execution under a Rule 10b5-1 plan indicates it's a pre-planned, non-discretionary transaction, mitigating concerns about it being based on new adverse information. Thus, the sentiment is neutral.

Negatives

• A significant institutional shareholder, the W.K. Kellogg Foundation Trust, reduced its stake in Kellanova by selling 114,583 shares.

Future Outlook

N/A

Management Comments

• The sales reported were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024, that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Industry Context

N/A

Corporate Governance

Related Party Transactions

• Sale of 114,583 shares of Kellanova common stock by the W.K. Kellogg Foundation Trust, a 10% owner and entity with director relationships, to the open market.

Stakeholder Impact

• Shareholders may note the reduction in stake by a significant institutional investor, though the pre-planned nature of the sale under Rule 10b5-1(c) suggests it is not based on new material non-public information.

Key Dates

Recommendation

The filing reports a pre-scheduled sale of shares by a significant institutional shareholder (W.K. Kellogg Foundation Trust) under a Rule 10b5-1 plan. While a large insider sale could be perceived negatively, the pre-planned nature mitigates concerns about it being based on new adverse information. This transaction is part of a routine portfolio management strategy rather than a signal of fundamental change in the company's outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Kellanova, K, W.K. Kellogg Foundation Trust, W.K. Kellogg Foundation, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership